GlobeNewswire by notified

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox

Share

COPENHAGEN, Denmark, July 22, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that the marketing authorization for the Company’s smallpox vaccine, IMVANEX®, is extended to include protecting people from monkeypox disease.

Data supporting the positive opinion was submitted upon request from EMA’s Emergency Task Force (ETF) in light of the current multi-country monkeypox outbreak.

The recommendation from the CHMP will be referred to the European Commission (EC) for final approval shortly. Once granted by the EC, the extended marketing authorization will be valid in all European Union Member States as well as in Iceland, Liechtenstein, and Norway.

Paul Chaplin, President, and CEO of Bavarian Nordic said: “We applaud the expedited review by the Committee for Medicinal Products for Human Use and the recommendation to extend the approval of our vaccine to include protection against monkeypox, thus aligning with the approvals from the US FDA and Health Canada. While we have already supplied our vaccine to many European countries during the current monkeypox outbreak, including supplies to the joint EU stockpile facilitated by the European Health Emergency Preparedness and Response Authority (HERA), the extension of the label will help to improve access to the vaccine throughout Europe and strengthen the future preparedness against monkeypox.”

About IMVANEX®
IMVANEX® (MVA-BN or Modified Vaccinia Ankara-Bavarian Nordic) is a non-replicating smallpox vaccine developed in collaboration with the U.S. government to ensure supply of a smallpox vaccine for the entire population, including immunocompromised individuals who are not recommended vaccination with traditional replicating smallpox vaccines. The vaccine was approved by the European Commission in 2013 for immunization against smallpox in adults aged 18 years and older and has subsequently gained regulatory approvals in Canada (marketed as IMVAMUNE®) and the U.S. (marketed as JYNNEOS®) where the approvals have been extended to include the monkeypox indication as the only vaccine having obtained this to-date.

Bavarian Nordic has ongoing supply contracts with USA and Canada and has delivered the vaccine to a number of undisclosed countries globally as part of their national biological preparedness. In recent years, smaller quantities of the vaccine have been supplied in response to sporadic cases of monkeypox. During the ongoing 2022 outbreak of monkeypox, Bavarian Nordic has worked with several governments to fulfil the immediate demand for the vaccine through a number of supply agreements and is working to secure manufacturing of vaccines to fulfil the demand in the medium- to long term.

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against monkeypox. The vaccine is also approved for protection against smallpox and monkeypox in Canada, and as a smallpox vaccine in Europe. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.

Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 29 / 2022

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Graduate Management Admission Council Appoints Joy Jones as Incoming CEO8.8.2022 18:00:00 CEST | Press release

Jones to succeed Sangeet Chowfla as head of the global association representing leading graduate business schools RESTON, Va., Aug. 08, 2022 (GLOBE NEWSWIRE) -- The Graduate Management Admission Council (GMAC), a global association of leading graduate business schools, today announced the appointment of Joy Jones as the organization’s CEO-Elect. Jones currently serves as GMAC’s chief product officer and general manager of assessments, a role she has held since July 2017. The announcement came after current CEO Sangeet Chowfla announced his intention to step down from the position earlier this year, and an extensive search executed by a global executive recruiting firm. The GMAC board of directors unanimously voted to elect Jones, who will become GMAC’s fourth CEO as of October 1, 2022. “With more than a hundred interested candidates from around the world, the Board conducted extensive interviews and thorough evaluations over the past months and was thrilled to find the best person to l

GeoJunxion (GOJXN.AS) announces the booking of a series of Location Intelligence Service contracts with combined value of well over one Million Euro8.8.2022 18:00:00 CEST | Press release

Capelle aan den IJssel, The Netherlands – 8 August 2022 – GeoJunxion (GOJXN.AS) is pleased to announce the booking of a series of Location Intelligence Service contracts with combined value of well over one Million Euro. The first 40 days of the new Financial Year 2022/23 (1 July 2022 - 30 June 2023) have been particularly busy and exciting for the various teams in GeoJunxion. As result of this, GeoJunxion is pleased to announce the booking of a series of Location Intelligence Services for one of its major global IT customers, with a combined value well over one Million Euro. In response to an increasing demand for hyper local content, GeoJunxion has closed a series of extensions to existing service contracts and successfully completed the negotiations on a large new tailor-made Location Intelligence Service contract. These new contracts will convert into revenue over the next 3 to 6 months and will contribute substantially to the continued growth of the company’s top- and bottom-line.

INVITATION TO CONFERENCE CALL FOR DFDS' REPORT FOR Q2 20228.8.2022 17:48:27 CEST | Press release

INVESTOR NEWS no. 22 - 8 August 2022 DFDS expects to publish the report for Q2 2022 on 16 August 2022 at around 07:30 CET. Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call. The presentation in English will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part. Date: 16 August 2022 Time: 10:00 CET Telephone: DK +45 35445577 UK +44 33 33000804 US +1 631 913 1422 Other international numbers: https://events-ftp.arkadin.com/ev/docs/NE_W2_TF_Events_International_Access_List.pdf Access code: 69612122# If you wish to take part in the audio conference, please dial up at least five minutes before the conference begins. It will start on time, and participants will be asked to register name and company name beforehand. The conference will be broadcast live on https://www.dfds.com/en/about and published there for future reference. Contact Søren Brøndholt Nielsen, IR +45 33 42 33 59 About DFDS DFDS provid

INVITATION TIL TELE-KONFERENCE OM DFDS' RAPPORT FOR 2. KVT. 20228.8.2022 17:48:27 CEST | pressemeddelelse

INVESTOR NEWS nr. 22 - 8. august 2022 DFDS’ kvartalsrapport for 2. kvt. 2022 forventes offentliggjort 16. august 2022 omkring kl. 07.30. Rapporten præsenteres på en tele-konference af Torben Carlsen, CEO og Karina Deacon, CFO. Efter præsentationen, der foregår på engelsk, vil der være mulighed for at stille spørgsmål. Investorer, analytikere og andre er velkommen til at deltage. Dato: 16. august 2022 Tidspunkt: Kl. 10.00 Telefonnumre: DK +45 35445577 UK +44 33 33000804 US +1 631 913 1422 Øvrige internationale telefonnumre: https://events-ftp.arkadin.com/ev/docs/NE_W2_TF_Events_International_Access_List.pdf Adgangskode: 69612122# Deltagere i tele-konferencen bedes ringe mindst fem minutter før starttidspunktet, da konferencen begynder rettidigt, og deltagere forinden skal registreres med navn og firmanavn. Tele-konferencen kan følges live på https://www.dfds.com/en/about og vil efterfølgende være tilgængelig på samme sted. Kontakt Søren Brøndholt Nielsen, IR +45 33 42 33 59 Om DFDS DFDS

Avance Gas Holding Ltd: 2022 Annual General Meeting8.8.2022 17:29:53 CEST | Press release

Hamilton, Bermuda 8 August 2022 - Avance Gas Holding Ltd (the "Company") advises that the 2022 Annual General Meeting of the Company will be held on September 30, 2022. The record date for voting at the Annual General Meeting is set to August 19, 2022. The notice, agenda and associated material will be distributed prior to the meeting. For further queries, please contact Executive Chairman: Øystein Kalleklev Tel: 47 23 11 40 00 About Avance Gas: Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carrier (VLGC) and operates a fleet of thirteen modern ships including two dual fuel LPG newbuidlings and has a further four dual fuel LPG newbuildings due for delivery in Q4 2022 and Q1-Q4 2023. For more information about Avance Gas, please visit www.avancegas.com. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities